Nicotine-mimicking molecules as medicine?
Stanford researchers discovered that a receptor that binds to nicotine and to clusters of beta-amyloid molecules is found on certain types of immune cells that can act as suppressors and regulators of the immune system.
Technique for quickly spotting TB
A newly created two-piece fluorescent probe gets activated when it comes in contact with tuberculosis bacteria in a phlegm.
Busting myths about milk
Milk is a good source of calcium but isn’t necessarily the most critical factor for bone health, according to a Stanford researcher who recently discussed the facts and “facts” about milk.
Computers help diagnose rare diseases
A Stanford method for comparing patients’ symptoms and gene data to the medical literature could greatly speed the diagnosis of rare genetic diseases.
Mystery of headaches, nausea
By the time she was 24, Rachel Hale was on her fourth diagnosis and had been on headache medication for years. Then she met with Ian Carroll, MD, a headache and orofacial pain specialist at Stanford.
New target for antibiotics
Boosting efforts to fight antibiotic resistance, Stanford researchers have found that a thin membrane, thought to be just a shrink wrap around some bacterial cell walls, has structural properties critical for survival.
Repeated DNA arrays can confer psychiatric risks
Repeated, human-specific DNA sequences are tied to an increased risk of psychiatric disorders, a Stanford study finds. It might be possible to treat the diseases with existing drugs.
How Biodesign technologies help patients
Stanford Biodesign trainees have developed new medical devices and diagnostics that have been used to help care for more than 1.5 million patients so far.
Toward a malaria vaccine for pregnant women
Prasanna Jagannathan said the $100,000 prize will allow his lab team to ramp up their research in Uganda.
Team seeks to decipher vulnerability to virus
Stanford researchers have joined forces to learn how immune cells in some kidney transplant patients fight a common virus. The work could lead to a test to predict who is at risk, and possibly develop new treatments.
New protein essential for making stem cells
The discovery by Stanford scientists drills a peephole into the black box of cellular reprogramming and may lead to new ways to generate induced pluripotent stem cells in the laboratory.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.